|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.45 USD | -0.09% |
|
-0.09% | -77.94% |
| 05-14 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 05-14 | The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
The Oncology Institute, Inc. reaffirmed financial guidance for the year 2022. For the year, the company expects revenue to be in the range of $270 to $310 million, representing approximately 33% to 53% growth over 2021 revenue.
| 1st Jan change | Capi. | |
|---|---|---|
| -77.94% | 33.5M | |
| +24.25% | 89.38B | |
| -24.01% | 75.67B | |
| +6.34% | 28.83B | |
| +4.85% | 18.25B | |
| -13.14% | 16.51B | |
| +2.09% | 15.72B | |
| +79.55% | 13.71B | |
| +79.66% | 13.46B | |
| +21.81% | 12.64B |
THE ONCOLOGY INSTITUTE, INC. 